HIGHLIGHTS
- who: Alexander M. Scherbakov and collaborators from the Department of Experimental Tumor Biology, Blokhin NNNational Medical Research Center of Oncology, Moscow , have published the paper: Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance, in the Journal: (JOURNAL)
- what: The study aims to analyze the effect of long-term incubation of ERu03b1-positive MCF7 breast cells with 4hydroxytamoxifen (HT) on their sensitivity to tubulin polymerization inhibitor docetaxel. Page 112 Scherbakov et_al Cancer Drug Resist 2023;6:103-15 Consistent with these facts, MCF7/HT in the study had the lowest activity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.